A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2011
10/20/2011	US20110256149 Antibody formulation
10/20/2011	US20110256148 Methods for Treating Hypercholesterolemia Using Antibodies to PCSK9
10/20/2011	US20110256134 Methods of treatment using anti-oxidized ldl antibodies
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma
10/20/2011	US20110256118 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
10/20/2011	US20110256113 Method for preventing and treating diabetes using neurturin
10/20/2011	US20110256110 Amniotic fluid cells and uses thereof
10/20/2011	US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011	US20110256063 Mex3c regulation and target to control obesity and diabetes
10/20/2011	DE102010015815A1 Use of glucose isomerase in therapy or diagnosis of diabetes and metabolic syndrome, preferably insulin resistance syndrome, and as food product, preferably dietary food, a dietary supplement or a food additive
10/20/2011	DE102010015242A1 Kombination aus Vitamin K und Nikotinamid Combination of vitamin K and nicotinamide
10/20/2011	DE102010015123A1 New benzylamidic diphenylazetidinone compounds, useful for treating lipid disorders, hyperlipidemia, atherosclerotic manifestations or insulin resistance, and for reducing serum cholesterol levels
10/20/2011	CA2799550A1 Stabilized statin formulations
10/20/2011	CA2796336A1 Methods for treating glucose metabolic disorders
10/20/2011	CA2796311A1 Fused derivatives as pi3k.delta. inhibitors
10/20/2011	CA2796064A1 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
10/20/2011	CA2796055A1 Human fgf receptor and .beta.-klotho binding proteins
10/20/2011	CA2795387A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	CA2795320A1 Method of treating obesity using antioxidant inflammation modulators
10/20/2011	CA2795101A1 Azacyclic spiroderivatives as hsl inhibitors
10/20/2011	CA2795078A1 Proteins that bind pi16 and uses thereof
10/19/2011	EP2377932A1 ANTI-Siglec-15 ANTIBODY
10/19/2011	EP2377875A1 Antioxidant
10/19/2011	EP2377864A1 Piperidine GPCR agonists
10/19/2011	EP2377863A1 Piperidine GPCR agonists
10/19/2011	EP2377855A1 A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases
10/19/2011	EP2377578A1 Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof
10/19/2011	EP2377524A1 Method of stabilizing reduced coenzyme Q10
10/19/2011	EP2376531A1 Novel insulin analogues
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP2376501A1 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
10/19/2011	EP2376462A1 Thiazoles as cannabinoid receptor ligands
10/19/2011	EP2376460A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
10/19/2011	EP2376123A2 Oligosaccharide-protein conjugates
10/19/2011	EP2376091A2 Novel targets for treatment of hypercholesterolemia
10/19/2011	EP2376077A2 Composition and method for treatment of diabetes
10/19/2011	EP2375899A1 Piperidine-containing compounds and use thereof
10/19/2011	EP1968601B1 Salts of potassium atp channel openers and uses thereof
10/19/2011	EP1967195B1 Antacid
10/19/2011	EP1899302B1 Phenoxy acetic acids as ppar delta activators
10/19/2011	EP1736206B1 Physiologically active composition and process for producing the same
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1383793B1 Insulin and igf-1 receptor agonists and antagonists
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN202011849U Equipment for extracting and concentrating polysaccharide from medicinal materials
10/19/2011	CN1874692B Lipid system and method of use
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102224138A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102223812A Modulation of infant fat mass
10/19/2011	CN102219864A Preparation method for water-soluble soybean polysaccharide trivalent ferric complex
10/19/2011	CN102219851A Preparation method for insulin glargine crystals
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102219849A Method for separating and purifying exenatide on large scale
10/19/2011	CN102219826A Polymorphs of sarsapogenin
10/19/2011	CN102219759A Aryl methanamide compounds and preparation method, medicinal compositions and application thereof
10/19/2011	CN102219720A Novel selenic acid biological material with anti-aging function
10/19/2011	CN102219670A Linear chain polyketone compounds and application thereof
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218141A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
10/19/2011	CN102218116A Traditional Chinese medicine for treating diabetes and preparation method thereof
10/19/2011	CN102218113A Medicinal composition for reducing blood sugar and method for preparing same
10/19/2011	CN102218111A Nutritional and healthcare traditional Chinese medicine for students
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218081A Manufacturing method of crocodile bone powder
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218064A Pharmaceutical combination with repaglinide and metformin as active components and preparation method thereof
10/19/2011	CN102218062A Medicine composition for treating diabetes mellitus
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218053A Application of luteolin in preparation of medicaments for inhibiting angiogenesis
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN102217694A Weight-reducing tea
10/19/2011	CN101920003B Traditional Chinese medicine composite for reducing fat and losing weight and preparation method thereof
10/19/2011	CN101904819B Method for preparing taurine particles
10/19/2011	CN101805308B Compound containing tyrosine and isoxazole skeleton and preparation method and application thereof
10/19/2011	CN101717399B Compound with pyrazine and thiazolone structure and application thereof in preparing medicament for treating diabetes mellitus
10/19/2011	CN101573300B Hydrogen-dissolved aqueous solution and method for prolonging the life duration of hydrogen dissolved in the aqueous solution
10/19/2011	CN101570515B Curcumin substituted uracil derivative, preparation method and use thereof
10/19/2011	CN101554385B Scalper bone chelate complex as well as preparation method and application thereof
10/19/2011	CN101549092B Quality control method of toxicant elimination and fat cleanness tablet
10/19/2011	CN101439075B Medicament for increasing high density lipoprotein, preventing and treating atherosclerosis, and preparation method thereof
10/19/2011	CN101421251B 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
10/19/2011	CN101390879B Composition containing tortoise serum and uses thereof
10/19/2011	CN101327200B Glycerol fruit sugar injection and preparation method thereof
10/19/2011	CN101280012B Exendin-4 active isomer and application thereof
10/19/2011	CN101268073B Heterocyclic compound, and production process and use thereof
10/19/2011	CN101107247B Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
10/18/2011	US8039508 Obesity therapy; mixture of lipase inhibitor orlistat and sucrose fatty acid ester
10/18/2011	US8039495 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
10/18/2011	US8039487 Piperidine-amide derivatives
10/18/2011	CA2551167C Aminoalcohol derivatives
10/18/2011	CA2494557C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents

1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 1298